Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Fuji
McKesson
Argus Health
Johnson and Johnson
Harvard Business School
Chinese Patent Office
Express Scripts
UBS
Cipla

Generated: February 21, 2018

DrugPatentWatch Database Preview

Sulfisoxazole diolamine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sulfisoxazole diolamine and what is the scope of sulfisoxazole diolamine freedom to operate?

Sulfisoxazole diolamine
is the generic ingredient in two branded drugs marketed by Roche and Sola Barnes Hind, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for sulfisoxazole diolamine.

US Patents and Regulatory Information for sulfisoxazole diolamine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sola Barnes Hind SULFISOXAZOLE DIOLAMINE sulfisoxazole diolamine SOLUTION/DROPS;OPHTHALMIC 084148-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche GANTRISIN sulfisoxazole diolamine SOLUTION/DROPS;OPHTHALMIC 007757-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche GANTRISIN sulfisoxazole diolamine OINTMENT;OPHTHALMIC 008414-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche GANTRISIN sulfisoxazole diolamine INJECTABLE;INJECTION 006917-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Citi
Deloitte
Baxter
Colorcon
Healthtrust
McKinsey
Covington
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot